Paloma Partners Management CO Horizon Therapeutics Public LTD CO Transaction History

Paloma Partners Management CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $331,955 - $477,030	5,634 New	5,634 $349,000
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $215,174 - $315,335	-2,710 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $298,235 - $378,954	-3,451 Reduced 56.01%	2,710 $285,000
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $133,844 - $162,837	-1,358 Reduced 18.06%	6,161 $664,000
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $2.24 Million - $2.69 Million	-24,412 Reduced 76.45%	7,519 $824,000
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $2.75 Million - $3.06 Million	31,931 New	31,931 $2.99 Million
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $635,120 - $844,234	-8,842 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $8.52 Million - $10.7 Million	-127,091 Reduced 93.5%	8,842 $647,000
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $7.01 Million - $10.1 Million	126,903 Added 1405.35%	135,933 $10.6 Million
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $272,706 - $514,529	9,030 New	9,030 $502,000
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $877,538 - $1.27 Million	-34,508 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $10.6 Million - $12.9 Million	-461,811 Reduced 93.05%	34,508 $940,000
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $11.3 Million - $14.1 Million	496,319 New	496,319 $11.9 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.